Effects of autoreactive T cells and cytokines in the pathogenesis of multiple sclerosis

International MS Journal

Volumn 9, Issue 1, 2002, Pages 29-35+28

  Weber, Frank ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; INTERLEUKIN 10; NERVE GROWTH FACTOR;

AUTOIMMUNE DISEASE; CELL LINE; CORRELATION ANALYSIS; DNA MODIFICATION; DRUG DELIVERY SYSTEM; HUMAN; KNOCKOUT MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; REMISSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 0036314560     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Axonal damage in acute multiple sclerosis lesions
2. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity
3. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?
4. Animal models
5. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4
6. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
7. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives
8. Late complications of immune deviation therapy in a nonhuman primate
9. Effector pathways in immune mediated central nervous system demyelination
10. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease
11. A critical role for lymphotoxin in experimental allergic encephalomyelitis
12. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice
13. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalo-myelitis (EAE)
14. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system
15. Primary demyelination in transgenic mice expressing interferon-gamma
16. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice
17. Interleukin-10 prevents experimental allergic encephalomyelitis in rats
18. IL-10 fails to abrogate experimental autoimmune encephalomyelitis
19. II-10 inhibits EAE
20. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
21. The adhesion molecule and cytokine profile of multiple sclerosis lesions
22. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
23. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis
24. T cells responsive to myelin basic protein in patients with multiple sclerosis
25. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
26. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis
27. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones
28. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals
29. Transformation of human T-cell clones by Herpesvirus saimiri: Intact antigen recognition by autonomously growing myelin basic protein-specific T cells
30. Synergistic immunomodulatory effects of interferon-α1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing remitting multiple sclerosis
31. Effect of IFN on human, MBP specific T cell lines: Comparison of IFN-1a and -1b
32. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99)
33. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals
34. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis
35. Genetic control of multiple sclerosis: Increased production of lymphotoxin and TNF-α by HLA-DK2+ T cells
36. Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes
37. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
38. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuro-protective role of inflammation?
39. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system
40. Genetic models for CNS inflammation
41. Gene transfer through the blood-nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis